M&G Investment Management’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $20.8M | Hold |
5,197,349
| – | – | 0.07% | 122 |
|
|
2023
Q3 | $15.6M | Hold |
5,197,349
| – | – | 0.07% | 149 |
|
|
2023
Q2 | $10.4M | Hold |
5,197,349
| – | – | 0.04% | 198 |
|
|
2023
Q1 | $10.4M | Hold |
5,197,349
| – | – | 0.05% | 180 |
|
|
2022
Q4 | $10.4M | Hold |
5,197,349
| – | – | 0.05% | 175 |
|
|
2022
Q3 | $15.6K | Buy |
5,197,349
+4,108,752
| +377% | +$12.3K | 0.09% | 140 |
|
|
2022
Q2 | $4.35K | Hold |
1,088,597
| – | – | 0.03% | 256 |
|
|
2022
Q1 | $5.44K | Hold |
1,088,597
| – | – | 0.01% | 247 |
|
|
2021
Q4 | $12K | Hold |
1,088,597
| – | – | 0.03% | 186 |
|
|
2021
Q3 | $17.4K | Hold |
1,088,597
| – | – | 0.04% | 216 |
|
|
2021
Q2 | $18.5K | Buy |
+1,088,597
| New | +$18.5K | 0.05% | 200 |
|